Clinical Outcome of Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer

Sasaki, Kenji; Yoda, Norihito; Onodera, Satoshi; Ootsuka, Kichiro; Domeki, Yasushi; Shida, Y.; Itoh, Yuuichi; Takahashi, Masakazu; Kaneko, Kei; Nakajima, Masahiro; Miyachi, Kazuhito; Kato, Hiroyuki

doi:10.3919/jjsa.72.1091

Cited by 4 publications

(3 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In terms of surgery for gastric cancer, Kitano et al first reported LDG in 1994 13 . Since, then, the number of patients receiving LDG has steadily increased, and the superiority of this procedure over open surgery has been established [14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32] . The 2014 guidelines for endoscopic surgery have classified LDG under level B (i.e., it is recommended) for gastric cancer patients with cStageI 33 .…”

Section: Discussionmentioning

confidence: 99%

The Influences of Obesity in Laparoscopic and Open Distal Gastrectomy for Patients with Early Gastric Cancer

Maejima¹,

Taniai

Yoshida

2022

J Nippon Med Sch

View full text Add to dashboard Cite

Background: A recent increase in the number of surgeries performed on obese patents has raised several issues. In this study, we examined the effects of obesity on laparoscopic and open distal gastrectomy.Methods: A total of 262 patients with gastric cancer (cStageI) who underwent distal gastrectomy were classified into open distal gastrectomy (ODG) (145 patients) and laparoscopic distal gastrectomy (LDG) (117 patients) groups. According to their body mass index (BMI), they were subdivided into obese (BMI ≥ 25) and non-obese patients (BMI < 25) to examine the duration of surgery, blood loss, the number of lymph node dissections, postoperative hospital stay, and incidence of postoperative complications. Results:The duration of surgery was longer and blood loss was higher for obese patients than for non-obese patients in both groups. The results for these two endpoints were significantly reduced in the LDG group than in the ODG group both in obese and nonobese patients. Furthermore, the number of lymph nodes dissected tended to be higher in the LDG group than in the ODG group in obese patients. Postoperative hospital stay was not significantly different between obese and non-obese patients in both groups, but was significantly shorter in the LDG group than in the ODG group regardless of the body weight. The incidence of postoperative complications was significantly higher in obese -3 -patients than in non-obese patients, although the difference between the groups was not significant. Conclusions:These findings indicate that LDG may be useful for obese patients with cStageI gastric cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

The Influences of Obesity in Laparoscopic and Open Distal Gastrectomy for Patients with Early Gastric Cancer

Maejima¹,

Taniai

Yoshida

2022

J Nippon Med Sch

View full text Add to dashboard Cite

show abstract

“…Gastric cancer (GC) remains one of the most common cancers in Asia because of the highly carcinogenic subtype of Helicobacter pylori (1) and salty food (2) . In more than half of patients with GC, the disease has recently been detected in the early stage due to the increased use of upper gastrointestinal endoscopy as a cancer screening modality (3) , and their prognoses have improved along with the development of minimally invasive surgery and the improvement of postoperative management (4) . Therefore, many patients survive long postoperative periods after surgical treatment.…”

Section: Introductionmentioning

confidence: 99%

Postoperative remission of diabetes mellitus after gastrectomy in patients with diabetes mellitus and gastric cancer

Mizukami

Kawaguchi

Shoda

et al. 2023

Preprint

View full text Add to dashboard Cite

Background/aim: We investigated the postoperative treatment status for diabetes mellitus and perioperative HbA1c levels in patients with diabetes mellitus and examined the effects of clinical factors on the remission of diabetes mellitus. Patients and methods: In this study, 126 patients with gastric cancer were considered to have diabetes mellitus preoperatively, of whom 79 were treated with oral antidiabetic drugs and/or insulin treatment. We compared diabetic treatment status and HbA1c values between the preoperative and postoperative periods in patients who underwent gastrectomy and examined the effects of clinical factors on improving diabetes mellitus. Results: Of the 79 patients treated preoperatively for diabetes mellitus, 34(43%) discontinued all medications for diabetes mellitus and 37 (47%) reduced the therapeutic dose or switched from insulin to oral antidiabetic drugs. Total gastrectomy was an independent factor for the remission of antidiabetic treatments after gastrectomy. Concerning the HbA1c level, only the absence of preoperative insulin use was an independent factor for the improvement. However, reconstruction was not a significant correlated factor for the improvement of postoperative HbA1c levels and the remission of antidiabetic medications after distal gastrectomy. Conclusions: Almost all patients discontinued or reduced the dose of antidiabetic medications after gastrectomy in clinical practice, and special attention should be paid in the management methods for diabetes mellitus in patients who underwent total gastrectomy for gastric cancer.

show abstract

“…Gastric cancer (GC) remains one of the most common cancers in Asia because of the highly carcinogenic subtype of Helicobacter pylori (1) and salty food (2). In more than half GC patients, the disease is detected in early stages due to increased use of upper gastrointestinal endoscopy as a cancer screening modality (3), and their prognoses have improved along with the development of minimally invasive surgery and the improvement of postoperative management (4). Therefore, many patients survive long postoperative periods after surgical treatment.…”

mentioning

confidence: 99%

Postoperative Remission of Diabetes Mellitus After Gastrectomy in Patients With Diabetes Mellitus and Gastric Cancer

MIZUKAMI,

KAWAGUCHI,

SHODA

et al. 2023

In Vivo

View full text Add to dashboard Cite

Background/Aim: We investigated the postoperative treatment status for diabetes mellitus and perioperative HbA1c levels in patients with diabetes mellitus and examined the effects of clinical factors on the remission of diabetes mellitus. Patients and Methods: In this study, 126 patients with gastric cancer were considered to have diabetes mellitus preoperatively, of whom 79 were treated with oral antidiabetic drugs and/or insulin treatment. We compared diabetic treatment status and HbA1c values between the preoperative and postoperative periods in patients who underwent gastrectomy and examined the effects of clinical factors on improving diabetes mellitus. Results: Of the 79 patients treated preoperatively for diabetes mellitus, 34 (43%) discontinued all medications for diabetes mellitus and for 37 (47%) the therapeutic dose was reduced or switched from insulin to oral antidiabetic drugs. Total gastrectomy was an independent factor for remission of antidiabetic treatments after gastrectomy. Concerning HbA1c levels, only the absence of preoperative insulin use was an independent factor for improvement. However, reconstruction was not a significantly correlated factor for the improvement of postoperative HbA1c levels and reduction of antidiabetic medications after distal gastrectomy. Conclusion: Almost all patients discontinued or had their dose of antidiabetic medications reduced after gastrectomy in clinical practice, and special attention should be paid in the management methods for diabetes mellitus in patients who underwent total gastrectomy for gastric cancer.

show abstract

Clinical Outcome of Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer

Cited by 4 publications

References 24 publications

The Influences of Obesity in Laparoscopic and Open Distal Gastrectomy for Patients with Early Gastric Cancer

The Influences of Obesity in Laparoscopic and Open Distal Gastrectomy for Patients with Early Gastric Cancer

Postoperative remission of diabetes mellitus after gastrectomy in patients with diabetes mellitus and gastric cancer

Postoperative Remission of Diabetes Mellitus After Gastrectomy in Patients With Diabetes Mellitus and Gastric Cancer

Contact Info

Product

Resources

About